Loading...
Skip to main content

SEP 17, 2024 | US | AGENCY SUBMISSION

US: Joint Letter to Congress re PREVAIL Act

We strongly urge you to oppose the Promoting and Respecting Economically Vital American Innovation Leadership Act (the “PREVAIL Act”), which was recently placed on the markup agenda. This bill would further weaken protections against abusive patent litigation, create unjustified obstacles to PTAB review, substantially degrade the performance of the PTAB, and significantly reduce patent quality and the ability of the patent system to promote technological progress.

Fazer o download do PDF